211 related articles for article (PubMed ID: 27650694)
21. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
[TBL] [Abstract][Full Text] [Related]
22. Who will benefit from noncurative resection in patients with gastric cancer with single peritoneal metastasis?
Xia X; Li C; Yan M; Liu B; Yao X; Zhu Z
Am Surg; 2014 Feb; 80(2):124-30. PubMed ID: 24480211
[TBL] [Abstract][Full Text] [Related]
23. Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.
Li S; Lan X; Gao H; Wang W; Chen L; Song S; Xue Y
Tumour Biol; 2017 Jun; 39(6):1010428317697567. PubMed ID: 28618957
[TBL] [Abstract][Full Text] [Related]
24. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
25. The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.
Saladino E; Fleres F; Mazzeo C; Pruiti V; Scollica M; Rossitto M; Cucinotta E; Macrì A
Anticancer Res; 2014 Apr; 34(4):2019-22. PubMed ID: 24692741
[TBL] [Abstract][Full Text] [Related]
26. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
28. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
29. Significant Role of Palliative Gastrectomy in Selective Gastric Cancer Patients with Peritoneal Dissemination: A Propensity Score Matching Analysis.
Nie RC; Chen S; Yuan SQ; Chen XJ; Chen YM; Zhu BY; Qiu HB; Peng JS; Chen YB
Ann Surg Oncol; 2016 Nov; 23(12):3956-3963. PubMed ID: 27380641
[TBL] [Abstract][Full Text] [Related]
30. Does upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis?
Kopanakis N; Efstathiou E; Sarris D; Spiliotis J
J BUON; 2017; 22(5):1144-1147. PubMed ID: 29135095
[TBL] [Abstract][Full Text] [Related]
31. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
32. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
Roviello F; Caruso S; Neri A; Marrelli D
Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.
Mahmoud AM; Ismail YM; Hussien A; Debaky Y; Ahmed IS; Mikhael HSW; Moneer M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):143-150. PubMed ID: 30472198
[TBL] [Abstract][Full Text] [Related]
34. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
Bonnot PE; Piessen G; Kepenekian V; Decullier E; Pocard M; Meunier B; Bereder JM; Abboud K; Marchal F; Quenet F; Goere D; Msika S; Arvieux C; Pirro N; Wernert R; Rat P; Gagnière J; Lefevre JH; Courvoisier T; Kianmanesh R; Vaudoyer D; Rivoire M; Meeus P; Passot G; Glehen O;
J Clin Oncol; 2019 Aug; 37(23):2028-2040. PubMed ID: 31084544
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal Carcinomatosis of Gastric Origin - Treatment Possibilities.
Hoskovec D; Krška Z; Dytrych P; Vočka M
Klin Onkol; 2019; 32(5):345-348. PubMed ID: 31610666
[TBL] [Abstract][Full Text] [Related]
37. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
[TBL] [Abstract][Full Text] [Related]
39. Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis.
Gremonprez F; Gossye H; Ceelen W
Eur J Surg Oncol; 2019 Mar; 45(3):366-370. PubMed ID: 30243468
[TBL] [Abstract][Full Text] [Related]
40. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]